30,825 Shares in AdaptHealth Corp. (NASDAQ:AHCO) Acquired by Seizert Capital Partners LLC

Key Points

• Seizert Capital Partners LLC has made a new investment in AdaptHealth Corp. (NASDAQ:AHCO), purchasing 30,825 shares worth approximately $334,000.
• Institutional investors hold a significant stake in AdaptHealth, with over 82.67% of the company's stock owned by various hedge funds and institutional investors.
• Research analysts have recently lowered their price targets for AdaptHealth shares, with an average rating of "Buy" and a consensus price target of $13.40.

Seizert Capital Partners LLC bought a new stake in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 30,825 shares of the company's stock, valued at approximately $334,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in AHCO. GAMMA Investing LLC lifted its stake in shares of AdaptHealth by 175.2% during the first quarter. GAMMA Investing LLC now owns 7,473 shares of the company's stock worth $81,000 after purchasing an additional 4,758 shares in the last quarter. Y Intercept Hong Kong Ltd acquired a new position in shares of AdaptHealth during the first quarter worth about $114,000. Guggenheim Capital LLC lifted its stake in shares of AdaptHealth by 10.1% during the fourth quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock worth $158,000 after purchasing an additional 1,525 shares in the last quarter. Legato Capital Management LLC purchased a new stake in shares of AdaptHealth during the first quarter worth about $167,000. Finally, KLP Kapitalforvaltning AS purchased a new stake in shares of AdaptHealth during the fourth quarter worth about $169,000. Institutional investors and hedge funds own 82.67% of the company's stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on AHCO. Truist Financial dropped their target price on AdaptHealth from $14.00 to $13.00 and set a "buy" rating on the stock in a research report on Monday, May 12th. Royal Bank Of Canada lowered their price objective on AdaptHealth from $14.00 to $13.00 and set an "outperform" rating for the company in a report on Thursday, May 8th. Five research analysts have rated the stock with a buy rating, According to MarketBeat, the company has an average rating of "Buy" and a consensus price target of $13.40.

AdaptHealth Stock Performance

Shares of NASDAQ:AHCO traded up $0.48 during trading on Monday, hitting $9.23. 450,619 shares of the company traded hands, compared to its average volume of 1,442,000. The stock has a market capitalization of $1.24 billion, a price-to-earnings ratio of 16.18, a PEG ratio of 0.84 and a beta of 1.58. The business's fifty day moving average is $9.04 and its 200-day moving average is $9.34. AdaptHealth Corp. has a one year low of $7.11 and a one year high of $11.70. The company has a quick ratio of 1.07, a current ratio of 1.29 and a debt-to-equity ratio of 1.25.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.